Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control
Yi An(Yale University), Jing Li(The University of Texas MD Anderson Cancer Center), Lauren E. Haydu(The University of Texas MD Anderson Cancer Center), Chad Tang(The University of Texas MD Anderson Cancer Center), Betty Y.S. Kim(The University of Texas MD Anderson Cancer Center), Jack M. Qian(South Shore Hospital), Patrick Hwu(Moffitt Cancer Center), Xin A. Wang(The University of Texas MD Anderson Cancer Center), Michael A. Davies(The University of Texas MD Anderson Cancer Center), Erik P. Sulman(NYU Langone Health), Veronica Chiang(Yale University), Anita Mahajan(Mayo Clinic in Arizona), James B. Yu(Harvard University), Paul D. Brown(Mayo Clinic), Penny Fang, Steven H. Lin(The University of Texas MD Anderson Cancer Center), James W. Welsh(The University of Texas MD Anderson Cancer Center), Wen Jiang(The University of Texas MD Anderson Cancer Center), Neil M. D’Souza(The University of Texas MD Anderson Cancer Center), Jennifer Logan(Massachusetts General Hospital), Harriet M. Kluger(Yale Cancer Center), Isabella C. Glitza(The University of Texas MD Anderson Cancer Center), Kenneth R. Hess(The University of Texas MD Anderson Cancer Center)
Cited by 70
Related Papers
Nivolumab plus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2013|4.2k
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
|Cell|2016|2.4k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
|Journal of Clinical Oncology|2014|2.2k